Inge Jedema

8PUBLICATIONS

52CO-AUTHORS

Gene and molecular therapyMolecular targetsProteins and peptidesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Epigenetics (incl. genome methylation and epigenomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|May 18, 2026

Phenotypic and Functional Characteristics of CD8+ T cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.

|Aug 05, 2025

Publisher Correction: Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.

Jessica S W Borgers, Divya Lenkala, Victoria Kohler

|Jan 14, 2025

Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies.

Thomas Kuilman, Deborah S Schrikkema, Jules Gadiot

|Jan 03, 2025

Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial.

Jessica S W Borgers, Divya Lenkala, Victoria Kohler

|Nov 28, 2022

Human T cells recognize HLA-DP-bound peptides in two orientations.

Sebastian Klobuch, Jia Jia Lim, Peter van Balen

|Sep 19, 2022

Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing.

W Huisman, M C J Roex, L Hageman

Pageof 2

Frequent Collaborators

John Haanen

Sebastian Klobuch

Peter van Balen

Matthijs D Linssen

Sofie Wilgenhof

Sebastian Hymson

Joong Hyuk F Sheen

Emily K Jackson

Yvonne Ware

Jessica S W Borgers

Frequent Collaborators

John Haanen

Sebastian Klobuch

Peter van Balen

Matthijs D Linssen